Congenital Bleeding Disorders
📧 Sign up to get email alerts when something new happens for Congenital Bleeding Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2014-03-26Clinical Trial Update: Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects [Phase 1]
A Phase 1 bioequivalence trial comparing Eptacog Alfa A 6 mg to NovoSeven in healthy male subjects has been withdrawn.